Lanean...
Modulating cGMP to Treat Lung Diseases
Background: Nitric oxide (NO) is constitutively produced in the lung by NO-synthases. The main cellular sources of lung NO production are the vascular endothelium and the airway epithelia (Bohle et al. 2000; German et al. 2000; Ide et al. 1999). Local NO production contributes to regulation of pulmo...
Gorde:
| Argitaratua izan da: | cGMP: Generators, Effectors and Therapeutic Implications |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7121669/ https://ncbi.nlm.nih.gov/pubmed/19089341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-540-68964-5_20 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|